| Prev Close | 0.96 |
| Open | 1.11 |
| Day Low/High | 0.97 / 1.11 |
| 52 Wk Low/High | 2.85 / 9.52 |
| Volume | 264.78K |
| Avg Volume | 872.30K |
| Exchange | NASDAQ |
| Shares Outstanding | 30.37M |
| Market Cap | 30.06M |
| EPS | -1.30 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Short Interest Expands By 14.2% For TROV
The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 442,930 share increase in total short interest for TrovaGene Inc , to 3,567,833, an increase of 14.17% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Phase 1 Safety Study Supports Planned Development Of PCM-075 In AML
Study evaluated safety, dose limiting toxicities, related maximum tolerated dose and indication of anti-tumor activity in patients with advanced or metastatic solid tumors
Short Interest Moves 16.3% Higher For TROV
The most recent short interest data has been released for the 04/28/2017 settlement date, which shows a 460,990 share increase in total short interest for TrovaGene Inc , to 3,292,918, an increase of 16.28% since 04/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Trovera™ EGFR Urine Liquid Biopsy Test Predictive Of Clinical Response To Therapy: Case Series In Patients With Non-Small Cell Lung Cancer
Authors conclude that ctDNA testing demonstrates clinical utility in assessing disease burden and response to therapy
TrovaGene (TROV) Is Today's Strong On High Volume Stock
Trade-Ideas LLC identified TrovaGene (TROV) as a strong on high relative volume candidate
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of TrovaGene, Inc.
Levi & Korsinsky announces it has commenced an investigation of TrovaGene, Inc.
EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Trovagene, Inc. - TROV
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Trovagene, Inc.
Short Interest Jumps 17.6% For TROV
The most recent short interest data has been released by the NASDAQ for the 02/12/2016 settlement date, which shows a 697,508 share increase in total short interest for TrovaGene Inc , to 4,657,297, an increase of 17.61% since 01/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Here’s Why TrovaGene (TROV) Stock is Soaring Today
TrovaGene (TROV) stock is spiking on Monday afternoon as the company enters an agreement with FedMed for access to cancer monitoring tests and services.
TrovaGene (TROV) Is Weak On High Volume Today
Trade-Ideas LLC identified TrovaGene (TROV) as a weak on high relative volume candidate
Trovagene (TROV) Stock Soars on America's Choice Provider Network Partnership
Trovagene (TROV) stock is climbing on heavy trading volume on Thursday after the company announced a partnership with America's Choice Provider Network.
Oversold Conditions For TrovaGene (TROV)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
